Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variants.
Several cell culture model systems in current use for studying tumour promotion mechanism are reviewed briefly. The conclusions that can be drawn from studies with the JB6 mouse epidermal system are summarized. Promoter-induced mitogenic stimulation, epidermal growth factor receptor binding and stimulated hexose transport are apparently not required for promotion of neoplastic transformation in JB6 cells by phorbol esters and other promoters. Phorbol ester receptor binding (or protein kinase C activation) and switched-off collagen synthesis may be required, but definitive proof is not available. Decreased cell surface trisialoganglioside synthesis and one or more genes that determine promotion sensitivity appear to distinguish sensitive from resistant cells and to be required for promotion of neoplastic transformation in JB6 cells.
D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D002999:Clone Cells; D004273:DNA, Neoplasm / Q000235:genetics; D004351:Drug Resistance; D005732:Gangliosides / Q000494:pharmacology; D005796:Genes; D014644:Genetic Variation; D051379:Mice; D051381:Rats; D012867:Skin / Q000166:cytology / Q000187:drug effects; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D014162:Transfection
D002273:Carcinogens; D004273:DNA, Neoplasm; D005732:Gangliosides; C016806:trisialoganglioside; D013755:Tetradecanoylphorbol Acetate